The Effect of PD01 on Cardiovascular Health and Microbial Environment

Exclusion Criteria

• •Type 2 diabetes mellitus (defined as fasting plasma glucose ≥ 7.0 mmol/L);
• •History of (severe) cardiovascular, respiratory, urogenital, gastrointestinal/hepatic, hematological/immunologic, HEENT (head, ears, eyes, nose, throat), dermatological/connective tissue, musculoskeletal, metabolic/nutritional, endocrine, neurological diseases, allergy, major surgery and/or laboratory assessments which might limit participation in or completion of the study protocol.
• •Abdominal surgery interfering with gastrointestinal function, upon judgment of the principle investigator)
• •Use of medication interfering with endpoints
• •Use of antioxidants, minerals and vitamin supplements available in pharmacies, drugstores, food markets or in alternative medicine
• •Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study (to be decided by the principle investigator), in the 180 days prior to the study
• •Use of antibiotics in the 90 days prior to the start of study
• •Known pregnancy, lactation
• •Abuse of products; alcohol (\> 20 alcoholic consumptions per week) and drugs
• •Smoking
• •Blood donation within 3 months before study period
• •Plans to lose weight or following a hypocaloric diet during the study period;
• •Weight gain or loss \> 3 kg in previous 3 months
• •High physical activity (\>4.5 hours of running/week)
• •Hormone replacement therapy (women)
• •History of any side effects towards intake of pro- or prebiotic supplements of any kind
• •History of any side effects towards intake of carotenoids
• •Prohibited use of pro-, pre- or synbiotics during study period and from one month prior to start of study.
• •High intake of fruits and vegetables (more than the 75th percentile of dietary intake of fruits and vegetables)
• •Vegetarians/vegans